Vaccine shows therapeutic promise against advanced melanoma – A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2, according to researchers from The University of Texas M. D. Anderson Cancer Center.
A crucial step towards large scale production of a vaccine against swine flu has been completed in the UK by the National Institute for Biological Standards and Control (NIBSC), part of the Health Protection Agency. – A strain of virus suitable for vaccine manufacture has now been produced and is being made available to the pharmaceutical industry and other flu laboratories.
GARDASIL? is First Cervical Cancer Vaccine to Receive WHO Pre-qualification — WHO Pre-qualification Will Help to Facilitate Expanded Global Access and Implementation of HPV Vaccination Programs. – GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant], Merck’s cervical cancer vaccine, has been awarded World Health Organization (WHO) pre-qualification. GARDASIL is the first cervical cancer vaccine to receive WHO pre-qualification.
AIDS Action Statement on HIV Vaccine Awareness Day: Reason to Hope. – Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone.
GSK has received orders from several governments aiming to stockpile a new candidate A (H1N1) adjuvanted influenza vaccine as a precautionary measure – Company to manufacture the new vaccine, once virus seed is made available by the WHO. – GSK is committed to supporting governments and health authorities around the world to respond to the emergence of the new A (H1N1) influenza strain.
Novel vaccine approach offers hope in fight against HIV – Gene transfer technology may lead to an HIV vaccine. – A research team may have broken the stubborn impasse that has frustrated the invention of an effective HIV vaccine, by using an approach that bypasses the usual path followed by vaccine developers.
Study indicates that a common virus could cause high blood pressure – Cytomegalovirus affects majority of adults worldwide. – A new study suggests for the first time that cytomegalovirus (CMV), a common viral infection affecting between 60 and 99 percent of adults worldwide, is a cause of high blood pressure, a leading risk factor for heart disease, stroke and kidney disease.
UCI awarded $45 million for infectious disease research. Facility seeks to improve detection, treatment and vaccine development. – The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded UC Irvine $45 million over five years for infectious disease research.
Studies of GARDASIL, Merck’s Cervical Cancer Vaccine, and HPV 16 Vaccine Component of GARDASIL Presented at International Papillomavirus Conference – In a study of an extended follow up of 290 women na?ve to HPV type 16, the HPV 16 component of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] was efficacious against HPV 16 infection for an average of 8.5 years after administration.
Keep swine flu leaflets safe – McGimpsey – Over 800,000 leaflets giving the public important information about swine flu will begin dropping through letter-boxes across Northern Ireland today.
Study demonstrates modest reduction in HIV disease progression, leads to new insights about HIV transmission. – A recently completed international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.
The world is better prepared for an influenza pandemic than at any time in history. – The world is better prepared for an influenza pandemic than at any time in history, thanks, in part, to vigilance and diligence of countries, Director-General Dr Margaret Chan said in her address to a special meeting of ASEAN+3 health ministers in Bangkok, Thailand.
